Delivery Order SPE2DB24D1205-SPE2DB25FCVMH

Award Date 4/2/25
Potential Completion Date 4/3/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $78,983.74 Firm Fixed Price delivery order is for the supply of MENOPUR 75 UNIT VIALS medical products. The contract has an ultimate completion date of March 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $102,044.44 delivery order is for MENOPUR 75 UNIT VIALS, a medical supply, under a Firm Fixed Price contract with a completion date of May 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,817.68 firm fixed price delivery order is for the supply of MENOPUR 75 UNIT VIALS, a specialty pharmaceutical product. The contract has a completion date of March 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,558.64, is for the delivery of MENOPUR 75 UNIT VIALS and has an ultimate completion date of December 31, 2024. The contract is a firm fixed-price agreement, with no set-aside designation indicated. Amerisourcebergen holds a significant...
This federal contract award, SPE2DX15D1022|SPE2DX24FVKAK, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $60,500.02 firm-fixed-price delivery order is for the supply of 4564983987 units of MENOPUR 75 unit vials. The contract has an ultimate completion date of June 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of 4,567,128,678 units of the pharmaceutical product Menopur 75 unit vials, with a total ceiling value of $57,087.30 and a period of performance through February 4, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,272.56 firm fixed-price delivery order is for 4,564,535,778 units of the drug MENOPUR 75. The award is not designated as a set-aside and is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, with ID SPE2DB20D3101|SPE2DB25FRAW9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,767.32 firm fixed-price delivery order is for the supply of 4,567,155,782 units of the drug MENOPUR 75. The contract has an ultimate completion date of February 5, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $16,680.48 firm fixed-price delivery order is for the supply of Menopur 75 unit vials, a specialty pharmaceutical product. The contract has a completion date of July 1, 2022 and was awarded on June 30, 2022. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,558.64 firm fixed-price delivery order is for 4566749515 MENOPUR 75 UNIT VIALS, with a completion date of December 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCVMH
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,960.45 fixed-price delivery order is for the supply of 4,567,776,245 units of the drug MENOPUR, with an ultimate completion date of April 3, 2025.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

This contract award was not designated with any set-aside requirements, indicating open competition.

Generated 7/2/25, 11:03 PM